Clinical trial to assess potential treatment for COVID-19-related respiratory failure

A team of physician-scientists are now enrolling patients in a clinical trial to evaluate a common anti-clotting drug for the treatment of COVID-19-positive patients with ARDS. The newly launched trial follows a special report the team published that suggested the use of a drug called tPA could reduce deaths among patients with ARDS as a complication of COVID-19.

from Top Health News -- ScienceDaily https://ift.tt/2yGYXjC